Company Overview and News

24
Merger Arbitrage Mondays - September 3, 2018

2018-09-04 seekingalpha
The Board of Trustees of LaSalle Hotel has determined that the non-binding proposal received from Pebblebrook Hotel Trust could reasonably be expected to lead to a “Superior Proposal."
RSYS CALL PEB

157
Merger Arbitrage Mondays: August 13, 2018

2018-08-13 seekingalpha - 1
Merger activity decreased last week with three new deals announced and one pending deal closing. We also had two deals that failed as discussed in the deal updates section below. After several years of low deal failures (more than 95% of all deals closed), 2018 has turned out to be a difficult year with 11 deals failing since the start of the year. Nearly half of these deals failed on account of regulatory issues.
RSYS CALL STDY RAD

 
140
Merger Arbitrage Mondays - July 16, 2018

2018-07-16 seekingalpha - 1
DOJ's challenge to AT&T and Time Warner’s merger could affect the bidding war between Disney and Comcast for Twenty-First Century Fox.
FOX STDY CMCSA RAD TWX CALL SXE GGP TWC FOXA

139
My 'Ten Commandments' Of Investing

2018-07-11 seekingalpha - 2
In this letter, I wish to share with you our investment strategy and summarize for you the logic behind our investment activities.
BAMGF NNUTU NNUTD CALL RAD AGO BAMKF BAM

138
Merger Arbitrage Mondays - July 9, 2018

2018-07-09 seekingalpha - 2
Perry Ellis International (PERY) confirmed receipt of a non-binding, unsolicited proposal from privately-held Randa Accessories Leather Goods.
MAT STDY RAD CALL GGP SXE

5
CALL / magicJack VocalTec Ltd. 8-K (Current Report)

2018-06-28 sec.gov - 1
UNITED STATES
CALL

4
magicJack VocalTec Ltd. Announces Receipt of ITA Withholding Tax Ruling Related to Pending Acquisition by B. Riley

2018-06-28 globenewswire
WEST PALM BEACH, Fla. and NETANYA, Israel, June 28, 2018 (GLOBE NEWSWIRE) -- magicJack VocalTec Ltd. (“magicJack”) (NASDAQ:CALL), a leading Voice over IP (VOIP) cloud-based communications company, announced today that it has received from the Israel Tax Authority (“ITA”) the “Withholding Tax Ruling” contemplated by the merger agreement among magicJack, B. Riley Financial, Inc. and B. R. Acquisition Ltd.
CALL

222
Merger Arbitrage Mondays - June 18, 2018

2018-06-19 seekingalpha - 1
Merger activity increased last week with two new deals announced and five pending deals closing. Several deals with large spreads on account of regulatory hurdles including Bayer's acquisition of Monsanto, AT&T's (NYSE:T) acquisition of Time Warner and China Oceanwide's acquisition of Genworth (NYSE:GNW) recently managed to get past those hurdles.
CAVM MRVL STDY RAD TWX NXPI WGL SXE MCHP TWC MSCC T CALL GNW QCOM GGP

5
CALL / magicJack VocalTec Ltd. 8-K (Current Report)

2018-05-10 sec.gov - 1
UNITED STATES
CALL

54
Kanen Files Preliminary Proxy Materials for the Election of Its Slate of Highly Qualified Directors at Aqua Metals' Upcoming 2018 Annual Meeting

2018-04-11 accesswire - 2
-Believes It is Critical for Aqua Metals to Immediately Retain a Credible and Qualified Interim CEO and Strongly Recommends Former Chief Commercial Officer Steve Cotton for This Role -Highlights Serious Concerns about the Company's Significant Underperformance and Poor Corporate Governance Practices -Reiterates Desire to Work Constructively with Aqua Metals to Reconstitute the Board, But Beliefs Substantial Change is Required to Reverse the Recent, Drastic Underperformance and Fix the Company's Governance
RSYS QBAK CTXAY ABCO UBNZF DAIO UBN CTX FTV S CVX CALL CTXAF INTC AQMS

40
Kanen Nominates Slate Of Four Highly Qualified Director Candidates For Election At Aqua Metals' 2018 Annual Meeting

2018-03-26 accesswire - 2
Believes Substantial Board Change Is Required to Reverse Years of Underperformance and Improve Operating Performance and Unlock Value
RSYS QBAK FTV S CALL INTC UBNZF DAIO AQMS UBN

Related Articles

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

2018-09-18 - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...

AGRX: Agile Therapeutics Analysis and Research Report

2018-09-18 - Asif

Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...

Silicon Investor Message Boards

This table lists all message boards related to CALL / magicJack VocalTec Ltd. on message board site Silicon Investor.

Calling all SI Poets Calling all SI Poets Calling all SI Poets For the Psychologically Oriented For the Psychologically Oriented For the Psychologically Oriented
Stock calls for fun - take this seriously at your risk Stock calls for fun - take this seriously at your risk Stock calls for fun - take this seriously at your risk Calls and Puts for Income Calls and Puts for Income Calls and Puts for Income
Callaway Golf -- itu0027s a buy Callaway Golf -- itu0027s a buy Callaway Golf -- itu0027s a buy Covered Calls For Income Production Covered Calls For Income Production Covered Calls For Income Production
Magic Jack = CALL Magic Jack = CALL Magic Jack = CALL Articles or research on possible company takeovers Articles or research on possible company takeovers Articles or research on possible company takeovers
Magic Jack Magic Jack Magic Jack The Covered Calls for Dummies Thread The Covered Calls for Dummies Thread The Covered Calls for Dummies Thread
CUSIP: M6787E101